Logo image of CASK

HERITAGE DISTILLING HOLDING (CASK) Stock Fundamental Analysis

NASDAQ:CASK - Nasdaq - US42727R1041 - Common Stock - Currency: USD

0.417  -0.05 (-11.3%)

After market: 0.401 -0.02 (-3.84%)

Fundamental Rating

0

Overall CASK gets a fundamental rating of 0 out of 10. We evaluated CASK against 33 industry peers in the Beverages industry. Both the profitability and financial health of CASK have multiple concerns. CASK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CASK had negative earnings in the past year.
In the past year CASK has reported a negative cash flow from operations.
CASK Yearly Net Income VS EBIT VS OCF VS FCFCASK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

CASK has a worse Return On Assets (-13.47%) than 84.85% of its industry peers.
Industry RankSector Rank
ROA -13.47%
ROE N/A
ROIC N/A
ROA(3y)-61.25%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CASK Yearly ROA, ROE, ROICCASK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 100 -100

1.3 Margins

CASK's Gross Margin of 25.54% is on the low side compared to the rest of the industry. CASK is outperformed by 87.88% of its industry peers.
In the last couple of years the Gross Margin of CASK has declined.
CASK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.16%
GM growth 5YN/A
CASK Yearly Profit, Operating, Gross MarginsCASK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

0

2. Health

2.1 Basic Checks

CASK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CASK has more shares outstanding
Compared to 1 year ago, CASK has an improved debt to assets ratio.
CASK Yearly Shares OutstandingCASK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M 4M 5M
CASK Yearly Total Debt VS Total AssetsCASK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -5.91, we must say that CASK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -5.91, CASK is doing worse than 81.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.91
ROIC/WACCN/A
WACC6.74%
CASK Yearly LT Debt VS Equity VS FCFCASK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M -20M -30M -40M

2.3 Liquidity

A Current Ratio of 0.23 indicates that CASK may have some problems paying its short term obligations.
CASK has a Current ratio of 0.23. This is amonst the worse of the industry: CASK underperforms 90.91% of its industry peers.
CASK has a Quick Ratio of 0.23. This is a bad value and indicates that CASK is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.05, CASK is not doing good in the industry: 93.94% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.05
CASK Yearly Current Assets VS Current LiabilitesCASK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

CASK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.13%, which is quite impressive.
CASK shows a small growth in Revenue. In the last year, the Revenue has grown by 5.41%.
Measured over the past years, CASK shows a small growth in Revenue. The Revenue has been growing by 0.46% on average per year.
EPS 1Y (TTM)100.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-489.6%
Revenue 1Y (TTM)5.41%
Revenue growth 3Y0.46%
Revenue growth 5YN/A
Sales Q2Q%-36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CASK Yearly Revenue VS EstimatesCASK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CASK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CASK Price Earnings VS Forward Price EarningsCASK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CASK Per share dataCASK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CASK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HERITAGE DISTILLING HOLDING

NASDAQ:CASK (7/17/2025, 8:07:25 PM)

After market: 0.401 -0.02 (-3.84%)

0.417

-0.05 (-11.3%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners4.63%
Inst Owner Change0%
Ins Owners25%
Ins Owner Change92.17%
Market Cap5.02M
AnalystsN/A
Price TargetN/A
Short Float %1.97%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.65
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.88
OCFYN/A
SpS0.65
BVpS-0.03
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.47%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.54%
FCFM N/A
ROA(3y)-61.25%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.16%
GM growth 5YN/A
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.05
Altman-Z -5.91
F-Score4
WACC6.74%
ROIC/WACCN/A
Cap/Depr(3y)17.47%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.1%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-489.6%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.41%
Revenue growth 3Y0.46%
Revenue growth 5YN/A
Sales Q2Q%-36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-33.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.26%
OCF growth 3YN/A
OCF growth 5YN/A